The Alzheimer’s Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science. AAIC 2021 will be held in a hybrid format — both in-person in Denver, USA and online. News media interested in covering the conference and receiving embargoed news materials should submit a request for press credentials.

On This Page:

• > News Media Registration and Credentials
• > Press Room Hours
• > News Embargo Policy
• > Scientific Abstracts
• > AAIC News Media Contacts
• > Spokespeople

News Media Registration and Credentials

Complimentary registration as a journalist for AAIC is solely for those individuals who will produce news coverage of the conference. News media outlets must be in existence and regularly (daily/weekly) covering health-related topics, including brain science/research, for at least six months to be eligible to receive embargoed news materials. Learn more about news media qualifications at AAIC.

News media must apply for press credentials and be approved in order to receive advance access to embargoed news materials. Approvals for news media/reporters are at the discretion of the Alzheimer’s Association.

Press Room Hours

News Embargo Policy

Please refer to the Guidelines for News Media for more information on the AAIC news embargo policy.

All materials presented at the Alzheimer's Association International Conference 2021 (AAIC) are embargoed for publication and broadcast until the date and time of presentation at the conference, or an embargo date and time specified by the Alzheimer's Association in advance. Please contact the Alzheimer’s Association Public Relations Department at AAICmedia@alz.org with any questions.

• The news embargo for abstracts and scientific presentations included in the AAIC news program will be listed on the news release that includes that abstract/presentation. The embargo must be adhered to regardless of the time of presentation at AAIC.
• News embargoes for live plenaries and oral sessions not included in the AAIC 2021 news program are at the beginning of each individual talk (not the overall session). For example, for an oral presentation session starting at 2 p.m. Mountain Time (North America) where each talk is 15 minutes long, the news embargo on the:
  • First talk = 2 p.m. MT
  • Second talk = 2:15 p.m. MT
  • Third talk = 2:30 p.m. MT
• All other conference abstracts, unless held by the AAIC news program, are embargoed until the start of the conference (7 a.m. MT on July 26, 2021) when they will be posted to the conference’s virtual platform.

All news media representatives, scientists, funders of science presented at AAIC, and AAIC exhibitors/sponsors agree to be bound by the AAIC news embargoes laid out in this policy, in addition to release times stated on news releases and other news materials issued by the Alzheimer’s Association and AAIC.

Embargoed AAIC news materials are intended specifically for each journalist's individual use and are not to be shared in any way with anyone until the news embargo date/time has passed. By accepting embargoed AAIC news materials, journalists acknowledge that the materials are solely for their use and that they will not distribute, publish, broadcast or in any other way share them before the news embargo time has passed.

If a reporter or news media outlet breaks an AAIC news embargo, the Alzheimer's Association reserves the right to revoke their press access and credentials for the current event and future Alzheimer's Association conferences and events.

Scientific Abstracts

AAIC abstracts, sessions and schedules will be available to registered journalists through a password protected website and the AAIC app. Data and details for abstracts included in the AAIC news program will not be on the website or app until the news embargo has passed.

AAIC News Media Contacts

Alzheimer's Association^® Public Relations Department
Phone: +1.312.335.4078
Email: AAICmedia@alz.org

Spokespeople

Maria C. Carrillo, Ph.D.
Chief Science Officer, Alzheimer's Association

Rebecca M. Edelmayer, Ph.D.
Director of Scientific Engagement, Alzheimer's Association

Carl V. Hill, Ph.D., MPH
Chief Diversity, Equity & Inclusion Officer, Alzheimer’s Association

Claire Sexton, DPhil
Director of Scientific Programs & Outreach, Alzheimer’s Association

Heather M. Snyder, Ph.D.
Vice President of Medical & Scientific Relations, Alzheimer's Association

Christopher Weber, Ph.D.
Director of Global Science Initiatives, Alzheimer’s Association